Mylan Executives Got Pay Increases As Price Of EpiPen Soared

Sam Levine
Updated

As the pharmaceutical company Mylan raised the price of the EpiPen, a device commonly used to counter allergic reactions, company executives got a big bump in compensation.

From 2007 to 2015, the company’s stock price more than tripled and the compensation of CEO Heather Bresch increased from $2,453,456 to $18,931,068, according to NBC News. Mylan President Rajiv Malik’s base pay increased 11.1 percent to $1 million in 2015, and Anthony Mauro, the company’s chief commercial officer, got a 13.6 percent increase in base pay, to $625,000, the network reported.

The price of a pack of two EpiPens has gone from $100 in 2008 to $500 this year. The easy-to-use device allows people to inject a predetermined amount of epinephrine (adrenaline) if they are having an allergic reaction.

That sharp increase has drawn scrutiny from lawmakers. Sen. Charles Grassley (R-Iowa), the chairman of the Senate Judiciary Committee, wrote to Bresch on Monday requesting that the company explain how it determined the pricing for the device. Sen. Amy Klobuchar (D-Minn.) also urged the Federal Trade Commission to investigate the company to determine whether it engaged in antitrust behavior.

“There does not appear to be any justification for the continual price increases of EpiPen. Manufacturing costs for the product have been stable and Mylan does not need to recover the product’s research and development costs because the product was on the market years before Mylan acquired it in 2007,” Klobuchar wrote in a letter to FTC Chair Edith Ramirez.

Democratic presidential nominee Hillary Clinton released a statement on Wednesday calling the increase in price “outrageous.”

“It’s just the latest troubling example of a company taking advantage of its consumers,” she said. “I believe that our pharmaceutical and biotech industries can be an incredible source of American innovation, giving us revolutionary treatments for debilitating diseases. But it’s wrong when drug companies put profits ahead of patients, raising prices without justifying the value behind them.”

In a statement to The Huffington Post last week, Mylan noted it has donated 650,000 EpiPen and EpiPen Jr auto-injectors to about half of all U.S. schools and said the vast majority of commercially insured patients received the EpiPen for free.

Bresch, the daughter of Sen. Joe Manchin (D-W.Va.), has been at the center of controversy before. In 2008, an investigation found that she didn’t complete the coursework required for an MBA from West Virginia University.

The FTC declined to say on Tuesday whether an investigation into Mylan was underway. Earlier this year, it opened an investigation into Turing Pharmaceuticals after it raised the price of Daraprim, a life-saving HIV drug, from $13.50 to $750 a tablet under CEO Martin Shkreli.

Shkreli weighed in on the Mylan controversy Wednesday, saying that the company should have better profits as the “sole supplier of a life-saving drug.”

This article has been updated with comments from Clinton and Shkreli.

Also on HuffPost

#5 Stimulants

While stimulants such as <a href="http://www.drugabuse.gov/drugs-abuse/commonly-abused-drugs/commonly-abused-prescription-drugs-chart" target="_hplink">Ritalin and Adderall</a> are highly addictive, abuse among older people is not as widespread as it with young adults. However, illicit stimulants like cocaine are more common. In 2008, <a href="http://oas.samhsa.gov/2k10/DAWN015/IllicitAbuse.htm" target="_hplink">63 percent of 118,495 emergency room visits</a> made by those 50 and older involved cocaine. The number of older cocaine users likely increased in the past few years since more than 550,000 adults aged 50 and older <a href="http://oas.samhsa.gov/2k11/013/WEB_SR_013.htm" target="_hplink">reported cocaine use</a>, according to a 2011 report. (<a href="http://www.flickr.com/photos/alexdoddphotography/3196151008/" target="_hplink">Image via Flickr</a>, Alex Dodd)

#4 Antidepressants

While the names are varied -- <a href="http://www.nimh.nih.gov/health/publications/mental-health-medications/what-medications-are-used-to-treat-depression.shtml" target="_hplink">Prozac, Zoloft and Lexapro</a>, among others -- the effects are similar. Used primarily to treat depression and mood disorders, antidepressants have a slight potential for abuse and addiction. According to a 2010 report from The Drug Abuse Warning Network, antidepressants contributed to <a href="http://www.samhsa.gov/data/2k10/WebSR018Pharma50+/Pharma50+HTML.pdf" target="_hplink">8.6 percent of emergency room visits</a> by adults 50 and older.

#3 Sedatives

Most often used to treat anxiety and insomnia, <a href="http://www.news-medical.net/health/List-of-Sedatives.aspx" target="_hplink">sedatives like Valium and Xanax</a> may become addictive <a href="http://nihseniorhealth.gov/drugabuse/improperuse/01.html" target="_hplink">if taken incorrectly, or used too often</a>. The Drug Abuse Warning Network identified sedatives, or depressants, as the pharmaceutical involved in <a href="http://www.samhsa.gov/data/2k10/WebSR018Pharma50+/Pharma50+HTML.pdf" target="_hplink">31.8 percent of emergency room visits by older adults</a>. (<a href="http://www.flickr.com/photos/deanslife/1359287762/" target="_hplink">Image via Flickr</a>, Dean812)

#2 Pain Relievers

Painkillers like Oxycodone, Vicodin and Morphine have a high potential for abuse. According to a Drug Abuse Warning Network report, <a href="http://www.samhsa.gov/data/2k10/WebSR018Pharma50+/Pharma50+HTML.pdf" target="_hplink">pain relievers were the type of pharmaceutical</a> most often involved in emergency room visits for post-50s, encompassing 43.5 percent of senior ER visits. The vast majority of painkiller-related ER visits -- 33.9 percent -- involved high-level narcotics, rather than over-the-counter pain relievers.

#1 Medical Marijuana

While many people have medical prescriptions for marijuana use, <a href="http://oas.samhsa.gov/2k11/013/WEB_SR_013.htm" target="_hplink">3 million adults aged 50 and older</a> have illegally used the drug within the past year, according to a 2011 report from The National Survey on Drug Use and Health, a branch of the U.S. Government's Department of Health and Human Services. Out of 4.8 million older adults who used illicit drugs, marijuana use was more common than non-medical use of prescription medicines among the 50 to 59 age range (though the opposite was true for those 60 and older). Marijuana is also far more popular among men than women aged 50 and older.

Love HuffPost? Become a founding member of HuffPost Plus today.

This article originally appeared on HuffPost.